Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 22.95
+0.45 (2.00%)
Sep 18, 2026, 10:58 AM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 893.36 million as of September 17, 2026. Its market cap has decreased by -50.76% in one year.
Market Cap
893.36M
Enterprise Value
851.51M
Revenue
464.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.95
ChartMarket Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 893.36M, a decrease of -46.84%. That is a compound annual growth rate of -10.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 893.36M | -64.32% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.49B |
| AViTA | 1.37B |
| Bioptik Technology Incorporation | 1.33B |
| S&S Healthcare Holding | 1.19B |
| Rossmax International | 1.04B |
| Wiltrom | 965.88M |
| AmCad BioMed | 896.16M |
| Cowealth Medical Holding | 774.79M |